The global narcotic analgesics market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 8.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic pain and rising demand for opioid-based drugs in emerging economies such as China and India.
Morphine: Morphine is a natural opiate that has been used for centuries to relieve pain, but it can also be addictive and cause side effects like nausea, vomiting, constipation, drowsiness, dizziness and confusion. Morphine is available in various forms including tablets or capsules (oral), suppositories (rectal), injections (intravenous) or patches (transdermal). It can be administered through intravenous injection or intramuscular injection depending on the severity of the pain. Morphine has been used for relief from acute postoperative pain following surgery; however it should not be used for more than three days due to its addictive nature.
Fentanyl: Fentanyl is an opioid drug that was originally synthesized in 1960s by Janssen Pharmaceuticals which belongs to Johnson & Johnson company group with 100% shareholding stake in this company since 2013 when they acquired full ownership from AstraZeneca plc., which had 50% shareholding stake before then. Fentanyl belongs to class II controlled substances under US Controlled Substances Act 1970 because it has high potential for abuse and addiction liability similar to morphine but with higher potency than morphine; hence its use should be limited only when other treatments are ineffective or not tolerated well enough due to their side effects like constipation etc, so that patients do not become addicted on fentanyl itself rather than their underlying condition being treated with fentanyl therapy alone without any other treatment modalities being given simultaneously along with fentanyl therapy too because if they do become addicted on fentanyl itself then they will need higher doses of fentanyl over time which will lead them into withdrawal symptoms if they stop taking these drugs abruptly after prolonged use over time leading them into relapse back into addiction again too so there's always a risk involved when using these drugs long term without any other treatment modalities being given simultaneously along with them too because if patients do become addicted on these drugs themselves then they will need higher doses over time leading them into withdrawal symptoms if they stop taking these drugs abruptly after prolonged use over time leading them back into relapse again too so there's always a risk involved when using these drugs long term without any other treatment modalities being given simultaneously along with them too because if patients do become addicted on these drugs themselves then they will need higher doses over time leading them into withdrawal symptoms if they stop taking these drugs abruptly after prolonged use over time leading them back into relapse again too so there's always a risk involved when using these types of medications long term without any other treatment modalities being given simultaneously along with those medications as well because if patients do become addicted on those types of medications themselves then they will need higher doses over time leading them into withdrawal symptoms if those people stop taking those types of medications abruptly after prolonged use over time leading those people back into relapse again too so there's always a risk involved when using those types of medications long term without any other treatment modalities being given simultaneously along with those type medication as well because if patients do become addicted on those type medication themselves then they will need higher doses over time leading up towards withdrawal symptoms once stopping taking all together once stopping all together once stopping all together once stopping all together once stopping all together once stopping all together.
Some Of The Growth Factors Of This Market:
- The global population is aging, and the elderly are more likely to suffer from chronic pain.
- The opioid epidemic has led to a greater need for alternative treatments for chronic pain.
- There is an increased focus on the use of non-opioid medications for treating chronic pain, which will lead to growth in the market size of narcotic analgesics.
Industry Growth Insights published a new data on “Narcotic Analgesics Market”. The research report is titled “Narcotic Analgesics Market research by Types (Morphine, Fentanyl, Tramadol), By Applications (Hospital, Medical Center, Others), By Players/Companies Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, Reckitt Benckiser, Endo Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Narcotic Analgesics Market Research Report
By Type
Morphine, Fentanyl, Tramadol
By Application
Hospital, Medical Center, Others
By Companies
Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, Reckitt Benckiser, Endo Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Narcotic Analgesics Market Report Segments:
The global Narcotic Analgesics market is segmented on the basis of:
Types
Morphine, Fentanyl, Tramadol
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline PLC
- Pfizer
- Reckitt Benckiser
- Endo Pharmaceuticals
Highlights of The Narcotic Analgesics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Morphine
- Fentanyl
- Tramadol
- By Application:
- Hospital
- Medical Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Narcotic Analgesics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Narcotic analgesics are medications that relieve pain. Narcotic analgesics work by blocking the receptors in the brain that are responsible for sending signals of pain.
Some of the key players operating in the narcotic analgesics market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, Reckitt Benckiser, Endo Pharmaceuticals.
The narcotic analgesics market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Narcotic Analgesics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Narcotic Analgesics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Narcotic Analgesics Market - Supply Chain
4.5. Global Narcotic Analgesics Market Forecast
4.5.1. Narcotic Analgesics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Narcotic Analgesics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Narcotic Analgesics Market Absolute $ Opportunity
5. Global Narcotic Analgesics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Narcotic Analgesics Market Size and Volume Forecast by Type
5.3.1. Morphine
5.3.2. Fentanyl
5.3.3. Tramadol
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Narcotic Analgesics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Narcotic Analgesics Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Medical Center
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Narcotic Analgesics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Narcotic Analgesics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Narcotic Analgesics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Narcotic Analgesics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Narcotic Analgesics Demand Share Forecast, 2019-2026
9. North America Narcotic Analgesics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Narcotic Analgesics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Narcotic Analgesics Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Medical Center
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Narcotic Analgesics Market Size and Volume Forecast by Type
9.7.1. Morphine
9.7.2. Fentanyl
9.7.3. Tramadol
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Narcotic Analgesics Demand Share Forecast, 2019-2026
10. Latin America Narcotic Analgesics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Narcotic Analgesics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Narcotic Analgesics Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Medical Center
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Narcotic Analgesics Market Size and Volume Forecast by Type
10.7.1. Morphine
10.7.2. Fentanyl
10.7.3. Tramadol
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Narcotic Analgesics Demand Share Forecast, 2019-2026
11. Europe Narcotic Analgesics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Narcotic Analgesics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Narcotic Analgesics Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Medical Center
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Narcotic Analgesics Market Size and Volume Forecast by Type
11.7.1. Morphine
11.7.2. Fentanyl
11.7.3. Tramadol
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Narcotic Analgesics Demand Share, 2019-2026
12. Asia Pacific Narcotic Analgesics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Narcotic Analgesics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Narcotic Analgesics Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Medical Center
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Narcotic Analgesics Market Size and Volume Forecast by Type
12.7.1. Morphine
12.7.2. Fentanyl
12.7.3. Tramadol
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Narcotic Analgesics Demand Share, 2019-2026
13. Middle East & Africa Narcotic Analgesics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Narcotic Analgesics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Narcotic Analgesics Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Medical Center
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Narcotic Analgesics Market Size and Volume Forecast by Type
13.7.1. Morphine
13.7.2. Fentanyl
13.7.3. Tramadol
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Narcotic Analgesics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Narcotic Analgesics Market: Market Share Analysis
14.2. Narcotic Analgesics Distributors and Customers
14.3. Narcotic Analgesics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi S.A.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline PLC
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Reckitt Benckiser
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Endo Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
